Aster Capital Management »

Lenz Therapeutics shares owned by Aster Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.2k 323 16.00

More positions owned by Aster Capital Management

Broadcom (AVGO)
Wal-Mart Stores (WMT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Exchange-traded Dj Internt Idx (FDN)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Comcast Corp Cl A (CMCSA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (XHB)
Mettler-Toledo International (MTD)
Iqvia Holdings (IQV)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Waters Corporation (WAT)
Globalfoundries Ordinary Shares (GFS)

View all positions for Aster Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
FMR
Falcon Edge Capital
Versant Venture Management
BlackRock
UBS Group
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Intrinsic Edge Capital Management
Millennium Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops

View all funds holding Lenz Therapeutics